Advertisement

Index by author

July 01, 2013; Volume 65,Issue 3

  1. Alexander, Stephen P. H.

    1. The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
      Francesco Di Virgilio
      Stephen P. H. Alexander, ASSOCIATE EDITOR, Department of Morphology, Surgery and Experimental Medicine, Section of General Pathology, University of Ferrara, Ferrara, Italy
      Pharmacological Reviews July 2013, 65 (3) 872-905; DOI: https://doi.org/10.1124/pr.112.006171
    2. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
      Anthony P. Davenport, Stephen P. H. Alexander, Joanna L. Sharman, Adam J. Pawson, Helen E. Benson, Amy E. Monaghan, Wen Chiy Liew, Chidochangu P. Mpamhanga, Tom I. Bonner, Richard R. Neubig, Jean Philippe Pin, Michael Spedding and Anthony J. Harmar
      Eliot H. Ohlstein, ASSOCIATE EDITOR, Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D.); School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, United Kingdom (S.P.H.A.); The University/BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom (J.L.S., A.J.P., H.E.B., A.E.M., W.C.L., C.P.M., A.J.H.); Section on Functional Neuroscience, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Department of Molecular Pharmacology, Institute of Functional Genomics, CNRS UMR5203, Universities Montpellier, Montpellier, France (J.P.P.); and Les Laboratoires Servier, Suresnes, France (M.S.)
      Pharmacological Reviews July 2013, 65 (3) 967-986; DOI: https://doi.org/10.1124/pr.112.007179

  2. Alexander, Stephen P.H.

    1. Adenosine Kinase: Exploitation for Therapeutic Gain
      Detlev Boison
      Stephen P.H. Alexander, ASSOCIATE EDITOR, Robert Stone Dow Neurobiology Laboratories, Legacy Research Institute, Portland, Oregon
      Pharmacological Reviews July 2013, 65 (3) 906-943; DOI: https://doi.org/10.1124/pr.112.006361

  3. Andersson, Dan

    1. Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
      Elisabet I. Nielsen and Lena E. Friberg
      Dan Andersson, ASSOCIATE EDITOR, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden
      Pharmacological Reviews July 2013, 65 (3) 1053-1090; DOI: https://doi.org/10.1124/pr.111.005769

  4. Andersson, Karl-Erik

    1. The Pharmacology of Regenerative Medicine
      George J. Christ, Justin M. Saul, Mark E. Furth and Karl-Erik Andersson
      Michael A. Nader, ASSOCIATE EDITOR, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina (G.J.C., K.-E.A.); Wake Forest Innovations, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina (M.E.F.); and Department of Chemical and Paper Engineering, Miami University, Oxford, Ohio (J.M.S.)
      Pharmacological Reviews July 2013, 65 (3) 1091-1133; DOI: https://doi.org/10.1124/pr.112.007393

  5. Benson, Helen E.

    1. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
      Anthony P. Davenport, Stephen P. H. Alexander, Joanna L. Sharman, Adam J. Pawson, Helen E. Benson, Amy E. Monaghan, Wen Chiy Liew, Chidochangu P. Mpamhanga, Tom I. Bonner, Richard R. Neubig, Jean Philippe Pin, Michael Spedding and Anthony J. Harmar
      Eliot H. Ohlstein, ASSOCIATE EDITOR, Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D.); School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, United Kingdom (S.P.H.A.); The University/BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom (J.L.S., A.J.P., H.E.B., A.E.M., W.C.L., C.P.M., A.J.H.); Section on Functional Neuroscience, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Department of Molecular Pharmacology, Institute of Functional Genomics, CNRS UMR5203, Universities Montpellier, Montpellier, France (J.P.P.); and Les Laboratoires Servier, Suresnes, France (M.S.)
      Pharmacological Reviews July 2013, 65 (3) 967-986; DOI: https://doi.org/10.1124/pr.112.007179

  6. Boison, Detlev

    1. Adenosine Kinase: Exploitation for Therapeutic Gain
      Detlev Boison
      Stephen P.H. Alexander, ASSOCIATE EDITOR, Robert Stone Dow Neurobiology Laboratories, Legacy Research Institute, Portland, Oregon
      Pharmacological Reviews July 2013, 65 (3) 906-943; DOI: https://doi.org/10.1124/pr.112.006361

  7. Bonner, Tom I.

    1. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
      Anthony P. Davenport, Stephen P. H. Alexander, Joanna L. Sharman, Adam J. Pawson, Helen E. Benson, Amy E. Monaghan, Wen Chiy Liew, Chidochangu P. Mpamhanga, Tom I. Bonner, Richard R. Neubig, Jean Philippe Pin, Michael Spedding and Anthony J. Harmar
      Eliot H. Ohlstein, ASSOCIATE EDITOR, Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D.); School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, United Kingdom (S.P.H.A.); The University/BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom (J.L.S., A.J.P., H.E.B., A.E.M., W.C.L., C.P.M., A.J.H.); Section on Functional Neuroscience, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Department of Molecular Pharmacology, Institute of Functional Genomics, CNRS UMR5203, Universities Montpellier, Montpellier, France (J.P.P.); and Les Laboratoires Servier, Suresnes, France (M.S.)
      Pharmacological Reviews July 2013, 65 (3) 967-986; DOI: https://doi.org/10.1124/pr.112.007179

  8. Cavallari, Larisa H.

    1. Pharmacogenetics and Cardiovascular Disease—Implications for Personalized Medicine
      Julie A. Johnson and Larisa H. Cavallari
      Rhian M. Touyz, ASSOCIATE EDITOR, Center for Pharmacogenomics, Department of Pharmacotherapy and Translational Research and Department of Medicine, Colleges of Pharmacy and Medicine, University of Florida, Gainesville, Florida (J.A.J.); and the Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois (L.H.C.)
      Pharmacological Reviews July 2013, 65 (3) 987-1009; DOI: https://doi.org/10.1124/pr.112.007252

  9. Christ, George J.

    1. The Pharmacology of Regenerative Medicine
      George J. Christ, Justin M. Saul, Mark E. Furth and Karl-Erik Andersson
      Michael A. Nader, ASSOCIATE EDITOR, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina (G.J.C., K.-E.A.); Wake Forest Innovations, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina (M.E.F.); and Department of Chemical and Paper Engineering, Miami University, Oxford, Ohio (J.M.S.)
      Pharmacological Reviews July 2013, 65 (3) 1091-1133; DOI: https://doi.org/10.1124/pr.112.007393

  10. Davenport, Anthony P.

    1. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
      Anthony P. Davenport, Stephen P. H. Alexander, Joanna L. Sharman, Adam J. Pawson, Helen E. Benson, Amy E. Monaghan, Wen Chiy Liew, Chidochangu P. Mpamhanga, Tom I. Bonner, Richard R. Neubig, Jean Philippe Pin, Michael Spedding and Anthony J. Harmar
      Eliot H. Ohlstein, ASSOCIATE EDITOR, Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D.); School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, United Kingdom (S.P.H.A.); The University/BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom (J.L.S., A.J.P., H.E.B., A.E.M., W.C.L., C.P.M., A.J.H.); Section on Functional Neuroscience, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Department of Molecular Pharmacology, Institute of Functional Genomics, CNRS UMR5203, Universities Montpellier, Montpellier, France (J.P.P.); and Les Laboratoires Servier, Suresnes, France (M.S.)
      Pharmacological Reviews July 2013, 65 (3) 967-986; DOI: https://doi.org/10.1124/pr.112.007179
« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue

Advertisement